<scp>BRAF V600E</scp> Mutation in Ganglioglioma: Impact on Epileptogenicity and Implications for Surgical Strategy
BRAF V600E status in patients with ganglioglioma-associated epilepsy is a potential biomarker to stratify the risk for seizure relapse after surgery. BRAF V600E-positive patients might benefit from a more aggressive surgical strategy.
Authors
- Eva Horner
- Karl Roessler (ORCID: https://orcid.org/0000-0002-9249-8082)
- Ekaterina Pataraia (ORCID: https://orcid.org/0000-0002-1454-7600)
- Thomas Czech (ORCID: https://orcid.org/0000-0001-8112-2795)
- Alexandra Lang (ORCID: https://orcid.org/0000-0003-1099-8989)
- Amedeo A. Azizi (ORCID: https://orcid.org/0000-0002-1347-6644)
- Gregor J. Kasprian (ORCID: https://orcid.org/0000-0003-3858-3347)
- Matthias Tomschik (ORCID: https://orcid.org/0000-0002-6243-1178)
- Christian Dorfer (ORCID: https://orcid.org/0000-0002-1843-7732)
- Martha Feucht (ORCID: https://orcid.org/0000-0001-7691-8158)
- Florian Mayer (ORCID: https://orcid.org/0000-0001-7219-413X)
- Christine Haberler
Institutions
- Comprehensive Cancer Center Vienna (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/ene.70136
- Citations
- 7
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 11.38
Funders
- Universität Wien
- Medizinische Universität Wien